EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions

Sergei Noskov, Anna Arefeva, Kseniia Radaeva, Igor Makarenko, Maria Gefen, Roman Drai

Clinical Pharmacology in Drug Development · 2024

DOI: 10.1002/cpdd.1435 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, 2024. Verfasst von Sergei Noskov und 5 weiteren Autor:innen. Beteiligte Einrichtung: City Hospital No. 3, Yaroslavl, Russia. Hauptthemen laut MEDLINE: Sofosbuvir, Therapeutic Equivalency, Cross-Over Studies, Carbamates. Die Arbeit nennt 24 Literaturangaben. Gefördert von: GEROPHARM, Russia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was conducted as a single‐site, open‐label, randomized, replicated crossover trial with 4 treatment periods. The aim was to evaluate the bioequivalence of a generic test drug containing velpatasvir and sofosbuvir compared to an established brand‐name medication in healthy White subjects under fasting conditions. Blood samples were collected at specified intervals up to 72 hours after dosing to measure the concentrations of velpatasvir and sofosbuvir using a certified high‐performance liquid chromatography with tandem mass spectrometry method. The bioequivalence of the 2 formulations was confirmed when statistical analysis showed that confidence intervals for the log‐transformed peak concentration and area under the concentration‐time curve from time 0 to the last quantifiable sample were within an acceptable range from 80% to 125%. Criteria for bioequivalence were met for both area under the concentration‐time curve from time 0 until the last quantifiable sample and peak concentration parameters. No adverse effects were reported during this trial in both groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SofosbuvirTherapeutic EquivalencyCross-Over StudiesCarbamatesFastingTabletsHeterocyclic Compounds, 4 or More RingsHealthy VolunteersArea Under CurveAntiviral AgentsHumansMaleAdultYoung AdultFemaleAdministration, OralTandem Mass SpectrometryDrug CombinationsMiddle AgedChromatography, High Pressure LiquidDrugs, GenericAdolescentBenzimidazolesBenzopyrans

Stichwörter der Autor:innen

bioequivalencegenerichepatitis Cpharmacokineticspharmacologysofosbuvirvelatasvir

Substanzen

SofosbuvirCarbamatesTabletsHeterocyclic Compounds, 4 or More RingsAntiviral AgentsvelpatasvirDrug Combinationssofosbuvir-velpatasvir drug combinationDrugs, GenericBenzimidazoles

Autor:innen und Institutionen

  • City Hospital No. 3, Yaroslavl, Russia.
  • R&D Center, GEROPHARM, Saint-Petersburg, Russia.

Förderung

  • GEROPHARM, Russia

Zitieren

APA

Noskov, S., Arefeva, A., Radaeva, K., Makarenko, I., Gefen, M., & Drai, R. (2024). Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1435

Vancouver

Noskov S, Arefeva A, Radaeva K, Makarenko I, Gefen M, Drai R. Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions. Clinical Pharmacology in Drug Development. 2024. doi:10.1002/cpdd.1435

BibTeX
@article{Noskov2024,
  author = {Noskov, Sergei and Arefeva, Anna and Radaeva, Kseniia and Makarenko, Igor and Gefen, Maria and Drai, Roman},
  title = {Bioequivalence Study of Velpatasvir/Sofosbuvir Oral Coated Tablets in Healthy Volunteers Under Fasting Conditions},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2024},
  doi = {10.1002/cpdd.1435}
}
Kostenlos starten →